CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Enzo Biochem Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Enzo Biochem Inc
60 EXECUTIVE BLVD
Phone: (516) 755-5500p:516 755-5500 FARMINGDALE, NY  11735  United States Ticker: ENZENZ
Business Summary
Enzo Biochem, Inc. is a global life science company. The Company's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through its global distribution network and licensing. The Company conducts its research and other product development efforts through internal research and collaborative relationships.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
7/31/20247/31/2023YesYes---

Industries
SIC Code Description
8071 Medical laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Steven J.Pully 64 10/26/2023 10/26/2023
Chief Executive Officer, Chief Operating Officer KaraCannon 55 1/31/2024 1/1/2011
Chief Financial Officer PatriciaEckert 46 1/31/2024 11/14/2022
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Enzo Life Sciences, Inc. 10 Executive Blvd Farmingdale NY United States

Business Names
Business Name
ENZ
Enzo Clinical Labs, Inc.
Enzo Life Sciences (ELS) AG
4 additional Business Names available in full report.

General Information
Number of Employees: 125 (As of 7/31/2024)
Outstanding Shares: 52,663,207 (As of 11/27/2024)
Shareholders: 685
Stock Exchange: NYSE
Federal Tax Id: 132866202
Email Address: info@corp.enzobio.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024